References
- Douglas Bryce. “The Acceptance of International (Foreign) Clinical Data: Trends for a New Decade.”. Symposium on International Drug Registration. International Federation of Pharmaceutical Manufacturers Association, Geneva, Switzerland October 2–5, 1979
- Grabowski H. G. “Public Policy and Innovation: The Case of Pharmaceuticals.”. Technovation. 1982; Vol. 1: 157–189
- James Barrie G. The Future of the Multinational Pharmaceutical Industry to 1990. Associated Business Programmes, London 1977
- National Council on Drugs. NCD Issues Positions on Swifter Drug Approval, Foreign Testing, Post-Marketing Surveillance and U.S. Clinical Research Decline. National Council on Drugs, New York November, 1981
- Peltier Hubert C. “The Ultimate Objective of Drug Research: Efficacy and Safety in Man.”. Symposium on International Drug Registration. International Federation of Pharmaceutical Manufacturers Association, Geneva, Switzerland October 2–5, 1979
- Phatak Arvind K. International Dimensions of Management. Kent Publishing Company, Boston 1983
- Reich Jack W. An Analysis of Drug Regulatory Affairs and Pharmaceutical Research and Development in France, Japan and the United States 1960–1980. University Microfilms, Ann Arbor, Michigan 1983, Ph.D. Dissertation
- Schwartzrman David. The Expected Return from Pharmaceutical Research :___Sources___of New Drugs and the Profitability of R&D Investment. American Enterprise Institute for Public Policy Research, Washington, D.C. May 19, 1975
- Schwartzman David. Innovation in the Pharmaceutical Industry. The Johns Hopkins University Press, Baltimore 1976
- Webster's Seventh New Collegiate Dictionary. G. & C. Merriam Company, Springfield, Massachusetts 1963